Senator Collins Urges DEA To Address 'Rainbow' Fentanyl & Illicit Pills That Target Teens & Young Adults
November 11, 2022
November 11, 2022
WASHINGTON, Nov. 11 -- Sen. Susan M. Collins, R-Maine, issued the following news release and letter:
In response to the growing prevalence of "rainbow" fentanyl and illicit pills laced with deadly fentanyl, U.S. Senator Susan Collins wrote to the U.S. Drug Enforcement Agency (DEA) to request an update on the progress being made to stem the flow of fentanyl reaching communities.
"The flood of counterfeit, fentanyl-laced pills falsely marketed as legitimate . . .
In response to the growing prevalence of "rainbow" fentanyl and illicit pills laced with deadly fentanyl, U.S. Senator Susan Collins wrote to the U.S. Drug Enforcement Agency (DEA) to request an update on the progress being made to stem the flow of fentanyl reaching communities.
"The flood of counterfeit, fentanyl-laced pills falsely marketed as legitimate . . .